Overview of primary monogenic dystonia

Parkinsonism and Related Disorders

Volumn 18, Issue SUPPL. 1, 2012, Pages

  Spatola, Marianna ^a   Wider, Christian ^a  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

Dystonia; DYT1; DYT18; DYT5; DYT6

Indexed keywords

BENZODIAZEPINE DERIVATIVE; BOTULINUM TOXIN; CHOLINERGIC RECEPTOR BLOCKING AGENT; GLUCOSE TRANSPORTER 1; LEVODOPA;

ARM MUSCLE; BRAIN DEPTH STIMULATION; CLINICAL FEATURE; DEVELOPMENTAL DISORDER; DISEASE ASSOCIATION; DOPA RESPONSIVE DYSTONIA; DYSTONIA; EARLY ONSET PRIMARY DYSTONIA; GENE DELETION; GENE MUTATION; GENE PRODUCT; HUMAN; KETOGENIC DIET; LIMB; LOW DRUG DOSE; MIXED TYPE PRIMARY TORSION DYSTONIA; MYOCLONUS DYSTONIA; NECK MUSCLE; PARKINSONISM; PAROXYSMAL EXERTION INDUCED DYSTONIA; PRIMARY GENERALIZED TORSION DYSTONIA; PRIMARY MONOGENIC DYSTONIA; PRIORITY JOURNAL; PSYCHOMOTOR DISORDER; RAPID ONSET DYSTONIA PARKINSONISM; REVIEW; SEIZURE; SLC2A1 GENE; THAP1 GENE; TOR1A GENE; TREMOR; UNSPECIFIED SIDE EFFECT;

EID: 84858648229     PISSN: 13538020     EISSN: 18735126     Source Type: Journal    
DOI: 10.1016/s1353-8020(11)70049-9     Document Type: Review

References (22)

1. Muller U. The monogenic primary dystonias. Brain 2009;132:2005-25.
2. Granata A, Warner TT. The role of torsinA in dystonia. Eur J Neurol 2010;17(1): 81-7.
3. Gordon KL, Glenn KA, Gonzalez-Alegre P. Exploring the influence of torsinA expression on protein quality control. Neurochem Res 2011;36:452-9.
4. Risch NJ, Bressman SB, Senthil G, Ozelius LJ. Intragenic Cis and Trans modification of genetic susceptibility in DYT1 torsion dystonia. Am J Hum Genet 2007;80:1188-93.
5. Vidailhet M, Vercueil L, Houeto JL, Krystkowiak P, Lagrange C, Yelnik J, et al. Bilateral, pallidal, deep-brain stimulation in primary generalised dystonia: a prospective 3 year follow-up study. Lancet Neurol 2007;6:223-9.
6. Fuchs T, Gavarini S, Saunders-Pullman R, Raymond D, Ehrlich ME, Bressman SB, et al. Mutations in the THAP1 gene are responsible for DYT6 primary torsion dystonia. Nat Genet 2009;41:286-8.
7. Bressman SB, Raymond D, Fuchs T, Heiman GA, Ozelius LJ, Saunders-Pullman R. Mutations in THAP1 (DYT6) in early-onset dystonia: a genetic screening study. Lancet Neurol 2009;8:441-6.
8. Kaffe M, Gross N, Castrop F, Fresel C, Gieger C, Lichtner P, et al. Mutational screening of THAP1 in a German population with primary dystonia. Parkinsonism Relat Disord 2011 Jul 20 [Epub ahead of print]. doi: 10.1016/j.parkreldis.2011.06.023.
9. Gavarini S, Cayrol C, Fuchs T, Lyons N, Ehrlich ME, Girard JP, et al. Direct interaction between causative genes of DYT1 and DYT6 primary dystonia. Ann Neurol 2010;68:549-53.
10. Groen JL, Ritz K, Contarino MF, van de Warrenburg BP, Aramideh M, Foncke EM, et al. DYT6 dystonia: mutation screening, phenotype, and response to deep brain stimulation. Mov Disord 2010;25:2420-7.
11. Furukawa Y. Update on dopa-responsive dystonia: locus heterogeneity and biochemical features. Adv Neurol 2004;94:127-38.
12. Segawa M, Nomura Y, Nishiyama N. Autosomal dominant guanosine triphosphate cyclohydrolase I deficiency (Segawa disease). Ann Neurol 2003; 54(6):S32-45.
13. Wider C, Melquist S, Hauf M, Solida A, Cobb SA, Kachergus JM, et al. Study of a Swiss dopa-responsive dystonia family with a deletion in GCH1: redefining DYT14 as DYT5. Neurology 2008;70:1377-83.
14. Thony B, Blau N. Mutations in the BH4-metabolizing genes GTP cyclohydrolase I, 6-pyruvoyl-tetrahydropterin synthase, sepiapterin reductase, carbinolamine-4adehydratase, and dihydropteridine reductase. Hum Mutat 2006;27:870-8.
15. Ichinose H, Ohye T, Takahashi E, Seki N, Hori T, Segawa M, et al. Hereditary progressive dystonia with marked diurnal fluctuation caused by mutations in the GTP cyclohydrolase I gene. Nat Genet 1994;8:236-42.
16. Leen WG, Klepper J, Verbeek MM, Leferink M, Hofste T, van Engelen BG, et al. Glucose transporter-1 deficiency syndrome: the expanding clinical and genetic spectrum of a treatable disorder. Brain 2010;133:655-70.
17. Pons R, Collins A, Rotstein M, Engelstad K, De Vivo DC. The spectrum of movement disorders in Glut-1 deficiency. Mov Disord 2010;25:275-81.
18. Suls A, Dedeken P, Goffin K, Van Esch H, Dupont P, Cassiman D, et al. Paroxysmal exercise-induced dyskinesia and epilepsy is due to mutations in SLC2A1, encoding the glucose transporter GLUT1. Brain 2008;131:1831-44.
19. Weber YG, Storch A, Wuttke TV, Brockmann K, Kempfle J, Maljevic S, et al. GLUT1 mutations are a cause of paroxysmal exertion-induced dyskinesias and induce hemolytic anemia by a cation leak. J Clin Invest 2008;118:2157-68.
20. Bovi T, Fasano A, Juergenson I, Gellera C, Castellotti B, Fontana E, et al. Paroxysmal exercise-induced dyskinesia with self-limiting partial epilepsy: a novel GLUT-1 mutation with benign phenotype. Parkinsonism Relat Disord 2011;17(6):479-81.
21. Weber YG, Kamm C, Suls A, Kempfle J, Kotschet K, Schule R, et al. Paroxysmal choreoathetosis/spasticity (DYT9) is caused by a GLUT1 defect. Neurology 2011; 77:959-64.
22. Akman CI, Engelstad K, Hinton VJ, Ullner P, Koenigsberger D, Leary L, et al. Acute hyperglycemia produces transient improvement in glucose transporter type 1 deficiency. Ann Neurol 2010;67:31-40.